In a Bank of America note published on Monday, the analyst argues that brand mail pharmacy margins can be 5-10% (and in many cases pharmacies are losing money on GLP-1 scripts), which are significantly lower than the 50% gross margins we estimate HIMS is capturing in its GLP-1 portfolio. It is unlikely that HIMS will follow Ros lead to partner with brand manufacturers, the analyst added, because HIMS differentiation and success is tied to its own brand equity for its products and selling branded pharmaceutical drugs would both hurt margins and cannibalize its core products. Diversifying Beyond the Major GLP-1 Drugs Hims could also look to broaden its weight loss offerings, leveraging its established telehealth platform to incorporate non-drug-based solutions
Improved Energy Levels: As weight decreases, many clients experience enhanced overall energy and vitality
District Judge Gordon J
Marketed as a multitasking anti-aging and regenerative molecule, GHK-Cu is now positioned as a next-generation active for skin repair, collagen induction, and antioxidant defense
In practice, they require data that most brokers dont have at their fingertips: carrier-level pricing comparisons, plan design benchmarks across size tiers, utilization patterns by product category, and the ability to model how different coverage configurations affect total plan cost